A new website educates visitors about the world's only CE and FDA-approved total artificial heart.

SynCardia Systems, Inc., manufacturer of the CardioWest Total Artificial Heart, has launched its new website at www.syncardia.com.

The Total Artificial Heart is used as a bridge to transplant in cardiac patients at risk of imminent death from biventricular failure. More than 800 devices have been implanted, accounting for more than 180 patient years.

Visitors to SynCardia's new website will find: clinical data documenting the successful use of the Total Artificial Heart as a bridge to transplant; patient stories and personal photos; and videos including news broadcasts, a National Geographic multimedia feature, patient interviews and educational animations.

SynCardia has applied for CE approval of a new discharge driver to power the Total Artificial Heart outside the hospital, enabling stable patients to wait for a donor heart at home.

The photo below shows Andrzej Bielak, who was successfully bridged to transplant by 544 days with the Total Artificial Heart.

Andrzej Bielak with SynCardia Total Artificial Heart